North America Patchouli Oil Market Size, Share & Industry Trends Analysis Report By Type (Light and Dark), By Application (Cosmetics & Personal Care, Medicine, Flavorings and Others), By Country and Growth Forecast, 2023 - 2030

North America Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type (Vitiligo, Melasma), By Treatment (Corticosteroids, Calcineurin Inhibitor, and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030


The North America Pigmentation Disorder Treatment Market would witness market growth of 4.2% CAGR during the forecast period (2023-2030).

The main factor promoting the development of the market is the rise in the number of people suffering from pigmentation disorders. Numerous nations have a large number of pigmentation disorder patients who need the development of effective pigmentation disorder treatments. In addition, rising demand for cutting-edge treatments for pigmentation disorders and increased government spending on the pharmaceutical and biotechnology industries in developing countries are predicted to positively impact the market. Furthermore, the market is anticipated to grow during the forecast period due to boosted awareness about pigmentation disorders.

Increasing emphasis on developing safe and effective pigmentation disorder treatments is one of the main trends in the market. Due to the prevalence of pigmentation disorders and the rise in demand for novel treatments, market participants emphasize developing and launching safe and effective treatments. This is anticipated to persist throughout the forecast period, driving market expansion.

North America experiences significant sun exposure, especially in regions with high ultraviolet (UV) radiation levels. Prolonged and unprotected sun exposure can cause various pigmentation disorders, including solar lentigines and melasma. The aging population in North America is growing, and many pigmentation disorders are more common with age. Age-related skin changes, such as solar lentigines and actinic keratosis, contribute to the prevalence of pigmentation disorders. North America is ethnically diverse, and individuals with skin of colour are susceptible to specific pigmentation disorders, such as melasma, post-inflammatory hyperpigmentation (PIH), and vitiligo. These conditions can affect a significant portion of the population. Thus, the increase in the prevalence of pigmentation disorder conditions in North America has been a notable trend in recent years, which is beneficial for the growth of the market.

The US market dominated the North America Pigmentation Disorder Treatment Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $315.2 million by 2030. The Canada market is experiencing a CAGR of 6.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.6% during (2023 - 2030).

Based on Type, the market is segmented into Vitiligo, Melasma, and Others. Based on Treatment, the market is segmented into Corticosteroids, Calcineurin Inhibitor, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, & Online Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Bausch Health Companies Inc, Glenmark Pharmaceuticals Limited, Obagi Cosmeceuticals LLC, AbbVie, Inc., Dermavant Sciences, Inc. (Roivant Sciences Ltd.), Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Galderma S.A., Viatris, Inc. (Mylan N.V.), and Pfizer, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Vitiligo
  • Melasma
  • Others
By Treatment
  • Corticosteroids
  • Calcineurin Inhibitor
  • Others
By Distribution Channel
  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Bausch Health Companies Inc
  • Glenmark Pharmaceuticals Limited
  • Obagi Cosmeceuticals LLC
  • AbbVie, Inc.
  • Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
  • Incyte Corporation
  • Dr. Reddy’s Laboratories Ltd.
  • Galderma S.A.
  • Viatris, Inc. (Mylan N.V.)
  • Pfizer, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Patchouli Oil Market, by Type
1.4.2 North America Patchouli Oil Market, by Application
1.4.3 North America Patchouli Oil Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. North America Patchouli Oil Market, by Type
4.1 North America Light Market, by Country
4.2 North America Dark Market, by Country
Chapter 5. North America Patchouli Oil Market, by Application
5.1 North America Cosmetics & Personal Care Market, by Country
5.2 North America Medicine Market, by Country
5.3 North America Flavorings Market, by Country
5.4 North America Others Market, by Country
Chapter 6. North America Patchouli Oil Market, by Country
6.1 US Patchouli Oil Market
6.1.1 US Patchouli Oil Market, by Type
6.1.2 US Patchouli Oil Market, by Application
6.2 Canada Patchouli Oil Market
6.2.1 Canada Patchouli Oil Market, by Type
6.2.2 Canada Patchouli Oil Market, by Application
6.3 Mexico Patchouli Oil Market
6.3.1 Mexico Patchouli Oil Market, by Type
6.3.2 Mexico Patchouli Oil Market, by Application
6.4 Rest of North America Patchouli Oil Market
6.4.1 Rest of North America Patchouli Oil Market, by Type
6.4.2 Rest of North America Patchouli Oil Market, by Application
Chapter 7. Company Profiles
7.1 Takasago International Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 Van Aroma
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.3 Ultra International B.V. (Ultra Group)
7.3.1 Company Overview
7.3.2 SWOT Analysis
7.4 PT Indesso
7.4.1 Company Overview
7.5 Symrise AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 Sensient Technologies Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Givaudan S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.6 SWOT Analysis
7.8 International Flavors & Fragrances, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segment & Regional Analysis
7.8.4 Research & Development Expense
7.8.5 SWOT Analysis
7.9 DSM-Firmenich
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 SWOT Analysis
7.10. NOW Health Group, Inc.
7.10.1 Company Overview
7.10.2 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings